Ken Grauer, MD
NOVEMBER 10, 2023
== — CLICK HERE — for a V ideo presentation of this case! Below are slides used in my video presentation. For full discussion of this case — See ECG Blog #220 — == The long lead II rhythm strip shown in Figure-1 was obtained from an 51-year-old man who presented to the ED ( Emergency Department ) with "palpitations" that began 1 hour earlier. HOW would you interpret this tracing?
Cassling
NOVEMBER 10, 2023
Breast cancer is the second most common cancer among women in the United States. Currently, it accounts for nearly 30% of all new female cancers each year. For 2023, the American Cancer Society estimated that 297,790 new cases of invasive breast cancer would be diagnosed and about 43,700 women would die from breast cancer. Despite the high number of diagnoses, the death rate from breast cancer has been decreasing steadily in the US since 1989.
The British Journal of Cardiology
NOVEMBER 10, 2023
It is no secret that the National Health Service (NHS) is currently screaming along in fifth gear just to stay on a country lane: and we haven’t yet reached the motorway that lies ahead. The NHS long-term plan couldn’t be more current, but it could perhaps have been more timely. 1 Successive governments have watched our population changing shape and ageing over the last 20 years, but a powerful response to that looming ‘motorway’ of healthcare demand has only now materialised.
American Heart News - Heart News
NOVEMBER 10, 2023
Statement Highlights: In-hospital cardiac arrest is a high-risk event among hospitalized patients of all ages worldwide and is associated with high rates of poor patient outcomes, including death.[1] Improving in-hospital cardiac arrest quality of.
The British Journal of Cardiology
NOVEMBER 10, 2023
Persistent cardiac arrhythmias are readily amenable to detection by performing a standard electrocardiogram (ECG), but detection of transient (paroxysmal) arrhythmias has long been a significant cause of frustration to both doctors and patients. Often a significantly symptomatic arrhythmia is experienced by the patient but terminates before an ECG can be recorded to allow diagnosis.
American Heart News - Heart News
NOVEMBER 10, 2023
Statement Highlights: The new American Heart Association PREVENTTM risk calculator estimates the 10- and 30-year risk of total cardiovascular disease for people aged 30 years and older. The calculator estimates the risk of heart attack, stroke and —.
Physiologically Speaking
NOVEMBER 10, 2023
Greetings! Welcome to the Physiology Friday newsletter. This newsletter is brought to you by Examine.com — the best place on the internet for health and nutrition information — and my new eBook, “VO2 Max Essentials.” Details can be found at the end of the post! Physiologically Speaking is a reader-supported publication.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
The New England Journal of Medicine
NOVEMBER 10, 2023
Overweight and obesity have reached epidemic proportions, affecting more than 70% of the U.S. adult population and more than 50% of persons worldwide.1 In addition to numerous health consequences, obesity contributes to cardiovascular disease indirectly through the development of risk factors and directly through various biologic mechanisms.
The British Journal of Cardiology
NOVEMBER 10, 2023
Andreas Grüntzig, an ardent angiologist crafted an indeflatable sausage-shaped dual-lumen balloon-catheter, designed its delivery to the heart, launched minimally invasive coronary intervention and taught by beaming live demonstration. Subsequent advances are just incremental tweaks and tinkers around this fully formed framework from 1978. The near-immediate or instant feedback learning process by which the heart responds to any new invasive procedural variation facilitates each new change; be i
The New England Journal of Medicine
NOVEMBER 10, 2023
In a trial in patients with cardiovascular disease and overweight or obesity but no diabetes, semaglutide was superior to placebo in lowering the risk of major adverse cardiovascular events at a mean follow-up of 39.8 months.
JAMA Cardiology
NOVEMBER 10, 2023
Systematic, standardized, and independent assessment of clinical trial end points is critical to protect the scientific integrity of clinical trials. Clinical event classification (CEC) has become the criterion standard for the process of event adjudication, which includes the creation of end point definitions; the identification of suspected events; the collection of information through dedicated case report forms, collection of medical records, and access to ancillary or administrative databas
The New England Journal of Medicine
NOVEMBER 10, 2023
In a randomized trial of PCI in patients with stable angina who were receiving little or no antianginal medication and had documented ischemia, PCI resulted in a better health status with respect to angina than placebo at 12 weeks.
HeartRhythm
NOVEMBER 10, 2023
In 2022 and 2023 Medtronic recalled implantable defibrillators because they may deliver less than full energy shocks. The 2022 problem truncates the 2nd phase of the waveform (SCP-T2), resulting in ∼32J shocks, and is mitigated by downloadable software; the 2023 malfunction truncates the 1st phase of the waveform, resulting in 0-12J shocks due to a glassed feedthrough problem (GFT-T1) that might be avoided by programming B>AX shock polarity.
The New England Journal of Medicine
NOVEMBER 10, 2023
In patients with myocardial infarction and anemia, a liberal transfusion strategy led to fewer deaths and heart attacks than a restricted transfusion strategy, but the difference was of borderline significance.
Circulation: Arrhythmia and Electrophysiology
NOVEMBER 10, 2023
Circulation: Arrhythmia and Electrophysiology, Ahead of Print. Background:Despite chronic therapies, atrial fibrillation (AF) leads to rapid ventricular rates (RVR) often requiring intravenous treatments. Etripamil is a fast-acting, calcium-channel blocker administered intranasally affecting the atrioventricular-node within minutes.Methods:ReVeRA evaluated efficacy and safety of etripamil for the reduction of ventricular rate (VR) in patients presenting urgently with AF-RVR (VR ≥110 bpm), was ra
Circulation
NOVEMBER 10, 2023
Circulation, Ahead of Print. Background:The optimal approach to identify individuals with diabetes who are at high-risk for developing heart failure (HF) to inform implementation of preventive therapies is unknown, especially in those without atherosclerotic cardiovascular disease (ASCVD).Methods:Adults with diabetes and no HF at baseline from 7 community-based cohorts were included.
HeartRhythm
NOVEMBER 10, 2023
There is an association between COVID-19 mRNA vaccination and the incidence or exacerbation of postural orthostatic tachycardia syndrome (POTS).
Circulation
NOVEMBER 10, 2023
Circulation, Ahead of Print. Background:Left bundle branch area pacing (LBBAP) may be associated with greater improvement in left ventricular ejection fraction and reduction in death or heart failure hospitalization when compared with biventricular pacing (BVP) in patients requiring cardiac resynchronization therapy (CRT). We sought to compare the occurrence of sustained ventricular tachycardia or ventricular fibrillation (VT/VF) and new onset atrial fibrillation (AF) in patients undergoing BVP
HeartRhythm
NOVEMBER 10, 2023
In arrhythmogenic right ventricular cardiomyopathy (ARVC), risk of atrial arrhythmias (AA) persists after ventricular tachycardia (VT) ablation.
Circulation: Cardiovascular Quality & Outcomes
NOVEMBER 10, 2023
Circulation: Cardiovascular Quality and Outcomes, Volume 16, Issue 11 , Page e010491, November 1, 2023.
Circulation: Cardiovascular Imaging
NOVEMBER 10, 2023
Circulation: Cardiovascular Imaging, Volume 16, Issue 11 , Page e014772, November 1, 2023.
HeartRhythm
NOVEMBER 10, 2023
Efficacy of beta blocker treatment in type 3 long QT syndrome (LQT3) remains debated.
Circulation: Cardiovascular Quality & Outcomes
NOVEMBER 10, 2023
Circulation: Cardiovascular Quality and Outcomes, Ahead of Print.
Circulation
NOVEMBER 10, 2023
Circulation, Ahead of Print. Background:Multivariable equations are recommended by primary prevention guidelines to assess absolute risk of cardiovascular disease (CVD). However, current equations have several limitations. Therefore, we developed and validated the AHA Predicting Risk of CVD EVENTs (PREVENT) equations among US adults aged 30-79 years without known CVD.Methods:The derivation sample included individual-level participant data from 25 datasets (N=3,281,919) between 1992-2017.
Science Daily - Heart Disease
NOVEMBER 10, 2023
The new American Heart Association PREVENTTM risk calculator estimates the 10- and 30-year risk of total cardiovascular disease for people aged 30 years and older. The calculator estimates the risk of heart attack, stroke and -- for the first time -- heart failure. The equations are sex-specific and race-free, acknowledging that race is not a biological factor, and can include an index of social determinants of health.
Circulation
NOVEMBER 10, 2023
Circulation, Volume 148, Issue 24 , Page 1982-2004, December 12, 2023. Cardiovascular-kidney-metabolic (CKM) syndrome is a novel construct recently defined by the American Heart Association in response to the high prevalence of metabolic and kidney disease. Epidemiological data demonstrate higher absolute risk of both atherosclerotic cardiovascular disease (CVD) and heart failure as an individual progresses from CKM stage 0 to stage 3, but optimal strategies for risk assessment need to be refine
JAMA Cardiology
NOVEMBER 10, 2023
This secondary analysis of a randomized clinical trial validates the findings of a single-center study regarding the use of natural language processing for the adjudication of heart failure hospitalization.
Expert insights. Personalized for you.
181 
Let's personalize your content